These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Studies with rubella vaccine (RA 27-3) using the subcutaneous and intranasal routes. Moffat MA, Gould JJ, Forbes FA, Freestone DS, Macdonald A. Scott Med J; 1972 Apr; 17(4):140-2. PubMed ID: 4554067 [No Abstract] [Full Text] [Related]
26. Important assumptions, extrapolations, and established facts which underlie the use of live rubella virus vaccines. Leedom JM, Wilkins J, Portnoy B, Salvatore MA. Am J Epidemiol; 1970 Sep; 92(3):151-7. PubMed ID: 5458941 [No Abstract] [Full Text] [Related]
34. Intranasal adminstration of HPV-77 rubella vaccine grown in WI-38. Lack of infection by this route. Newman SJ, Sever JL, Fuccillo DA. Lancet; 1969 Sep 27; 2(7622):665-6. PubMed ID: 4185410 [No Abstract] [Full Text] [Related]
38. Discussion paper: the use of primates in experimental viral infections--rubella and the rubella syndrome. Horstmann DM. Ann N Y Acad Sci; 1969 Jul 03; 162(1):594-7. PubMed ID: 4979569 [No Abstract] [Full Text] [Related]
39. Studies on live rubella vaccine. II. Field trials with two experimental vaccine strains. Minekawa Y, Suzuki N, Takahashi M, Okuno Y. Biken J; 1968 Dec 03; 11(4):243-50. PubMed ID: 5721530 [No Abstract] [Full Text] [Related]